ConvaTec Group PLC (LSE:CTEC) - Share price - Overview

Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX118.55

Day Change
-1.65|-1.37%

As of 15/02/2019
18:45:01 GMT | GBX
Minimum 15 Minutes Delay.

Last Close120.20p
Day Range115.30 - 121.00
Mkt Cap2.33Bil
52-Wk Range113.25 - 41,408.93
Yield %0.00
ISINGB00BD3VFW73
Volume20,254,007
P/E1,500.63
P/S1.31
P/CF7.55

Share Price

Total Returns 15/02/2019

 Chg (%)  
More ...
ConvaTec Group PLC-13.31 
FTSE 100 TR GBP5.30
 
Financials
201520162017
More ...
Income Statement
Turnover1,650.401,688.301,764.60
Operating Profit230.40154.00247.80
Net Profit-93.40-202.80158.40
Reported EPS-0.05-0.150.08
Balance Sheet
Current Assets757.20765.20875.10
Non Current Assets3,034.202,743.102,925.80
Total Assets3,791.403,513.903,800.90
Current Liabilities285.60300.00323.10
Total Liabilities4,010.202,267.702,277.10
Total Equity-218.801,246.201,523.80
Cash Flow
Operating Cash Flow142.50113.90353.50
Net Change in Cash55.1015.704.70

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
24/10/2018PurchaseRick D. Anderson153.6875,000115,259.00
15/10/2018PurchaseMr. Jesper Ovesen141.8040,00056,720.00
15/10/2018PurchaseMr. Jesper Ovesen141.305,0007,065.00
15/10/2018PurchaseFrank Schulkes150.4265,00097,773.00

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Sector

Medical Instruments & Supplies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 07/03/2019

Annual Report
Ratios
Comp
More ...
PER (E)15.61
Div Yld (E)3.08
PEG (E)2.85
ROCE6.40
Op Mrgn0.14
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date06/04/1807/09/18
Ex-Div05/04/1806/09/18
Paid17/05/1812/10/18
Amnt3.091.31
Directors
More ...
Non-Executive DirectorMr. Jesper Ovesen
Non-Executive Director, ChairmanSir Christopher Charles Gent
Executive Director, Chief Executive Officer (Interim)Rick D. Anderson
Non-Executive Director, Deputy ChairmanSteven John Holliday
Non-Executive DirectorDr. Rosalind Catherine Rivaz
Executive Director, Chief Executive OfficerMr. Paul Moraviec
Executive Director, Chief Financial OfficerFrank Schulkes
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.